A 5-MONTH-OLD male infant was admitted to the hospital with a 3-day history of fever associated with anorexia, fussiness, and decreased sleep. Information from a review of systems and history of present illness revealed a several-week history of constipation and gastroesophageal reflux. On physical examination the infant appeared healthy and had a nontender, firm, abdominal mass palpated in the right upper quadrant. The mass extended 9 cm below the costal margin. By auscultation, bowel sounds were present, and a diffuse low-pitched bruit was heard over the mass. Findings from the remainder of the physical examination were unremarkable.
mal. The complete blood cell count was remarkable for a hemoglobin level of 91 g/L and a platelet count of 203 ϫ 10 9 /L. Urine catecholamine levels were normal. His ␣ 1 -fetoprotein level was greater than 60 µg/L (reference range, 0-15 µg/L). An abdominal radiograph showed an upper abdominal mass crossing the midline not seen on radiography performed 2 months earlier during evaluation of the patient's gastroesophageal reflux. An abdominal ultrasonogram (Figure 1) and a computed tomographic scan (Figures 2, 3, and 4) of the abdomen were performed. H emangioendothelioma of the liver is the most frequent vascular tumor diagnosed during the newborn period. It is a benign, solitary or multicentric highly vascular tumor that arises from supporting tissues of the liver and skin.
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Denouement and Discussion
Hemangioendothelioma of the Liver
1 A hemangioendothelioma may develop areas of fibrosis, calcification, hemorrhage, or cystic degeneration, and it typically enlarges during the first 1 to 6 months of life. 1 The natural history involves regression and complete or nearcomplete involution by age 12 to 18 months. 1, 2 These vascular tumors are symptomatic 85% of the time. 3 Symptoms usually are present by age 2 months. 3 The most serious complication is high-output congestive heart failure, which requires vigorous therapy with digitalis, diuretics, and oxygen, with planned, definitive treatment of the hemangioendothelioma. [1] [2] [3] The younger the patient at presentation, the more severe the cardiac failure. 2 Other complications are consumptive coagulopathy and thrombocytopenia (Kasabach-Merritt syndrome), respiratory and feeding problems owing to compression of neighboring structures, hepatic rupture, and hemorrhage. 1, 2, 4 The ultrasonographic appearance of a hemangioendothelioma is a highly echogenic, a complex, or a hypoechoic mass.
1 Dynamic, contrast-enhanced computed tomography is diagnostic for hemangioendothelioma of the liver. 1 Hemangioendotheliomas appear as multiple round or oval, well-circumscribed, homogeneous, hypodense masses that initially enhance at the periphery with progressive centripetal filling in of enhancement after intravenous injection. 1 Washout of the contrast medium occurs within 5 minutes of administration. 1 Radionuclide or magnetic resonance imaging can be helpful. Radionuclide scintigraphy with technetium Tc 99m-labeled erythrocytes shows increased activity during the blood-pool phase and on delayed imaging. 1 On magnetic resonance imaging, hemangioendotheliomas are well-defined masses with lower signal intensity than normal liver tissue on T1-weighted images and higher signal intensity on T2-weighted images. 1 After the administration of gadolinium diethylenetriamine pentaacetic acid, progressive centripetal enhancement is observed. 1 Laboratory data may indicate consumptive coagulopathy.
1,2,5 ␣ 1 = Ffetoprotein levels are usually moderately increased. 2 Hemangioendotheliomas are known to regress spontaneously; however, treatment of complications is often necessary. Medical therapy includes corticosteroids and interferon alfa-2A. [1] [2] [3] [4] Corticosteroids have shown a 30% to 60% response rate. 3 Interferon alfa-2A inhibits capillary endothelial cell migration, endothelial cell proliferation in vitro, and angiogenesis in animals. 3 Surgical therapy is used if the hemangioendothelioma is solitary or has minimal collateral vessels. [1] [2] [3] The hemangioendothelioma may be excised by partial hepatectomy or its afferent vessels can be embolized or ligated. [1] [2] [3] Our patient was initially treated for 2 months with daily subcutaneous injections of 2 million U/m 2 of IFN-␣-2A, but he showed no notable response. He was then treated with high-dose systemic steroids for 1 1 ⁄2 months with initial involution of the hemangioendothelioma. Seven months after diagnosis, he continues treatment with interferon alfa-2A. Almost 50% of pediatric liver tumors are benign. 6 Differentiation of a benign hepatic mass from a malignant hepatic mass, such as hepatoblastoma, is essential. 
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